These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 38556550)

  • 1. Recent advances in CRISPR-based functional genomics for the study of disease-associated genetic variants.
    Kim HS; Kweon J; Kim Y
    Exp Mol Med; 2024 Apr; 56(4):861-869. PubMed ID: 38556550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applying gene-editing technology to elucidate the functional consequence of genetic and epigenetic variation in Alzheimer's disease.
    Schrauben M; Dempster E; Lunnon K
    Brain Pathol; 2020 Sep; 30(5):992-1004. PubMed ID: 32654206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to Identify Genetic Variants Causing Infertility.
    Ding X; Schimenti JC
    Trends Mol Med; 2021 Aug; 27(8):792-806. PubMed ID: 33431240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allele-specific genome targeting in the development of precision medicine.
    Wu J; Tang B; Tang Y
    Theranostics; 2020; 10(7):3118-3137. PubMed ID: 32194858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Developments in CRISPR/Cas-based Functional Genomics and their Implications for Research Using Zebrafish.
    Prykhozhij SV; Caceres L; Berman JN
    Curr Gene Ther; 2017; 17(4):286-300. PubMed ID: 29173171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR: Groundbreaking technology for RNA-guided genome engineering.
    Cong L
    Anal Biochem; 2017 Sep; 532():87-89. PubMed ID: 28479380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deconstructing cancer with precision genome editing.
    Johnson GA; Gould SI; Sánchez-Rivera FJ
    Biochem Soc Trans; 2024 Apr; 52(2):803-819. PubMed ID: 38629716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linking genome variants to disease: scalable approaches to test the functional impact of human mutations.
    Findlay GM
    Hum Mol Genet; 2021 Oct; 30(R2):R187-R197. PubMed ID: 34338757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translating genomic insights into cardiovascular medicine: Opportunities and challenges of CRISPR-Cas9.
    Zhang Y; Karakikes I
    Trends Cardiovasc Med; 2021 Aug; 31(6):341-348. PubMed ID: 32603681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Cas9 human gene replacement and phenomic characterization in
    McDiarmid TA; Au V; Loewen AD; Liang J; Mizumoto K; Moerman DG; Rankin CH
    Dis Model Mech; 2018 Nov; 11(12):. PubMed ID: 30361258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Genomics via CRISPR-Cas.
    Ford K; McDonald D; Mali P
    J Mol Biol; 2019 Jan; 431(1):48-65. PubMed ID: 29959923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling human disease in rodents by CRISPR/Cas9 genome editing.
    Birling MC; Herault Y; Pavlovic G
    Mamm Genome; 2017 Aug; 28(7-8):291-301. PubMed ID: 28677007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas system: A game changing genome editing technology, to treat human genetic diseases.
    Hussain W; Mahmood T; Hussain J; Ali N; Shah T; Qayyum S; Khan I
    Gene; 2019 Feb; 685():70-75. PubMed ID: 30393194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision genome editing in the CRISPR era.
    Salsman J; Dellaire G
    Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of genome editing tools in precision medicine research.
    Li S; Yang YY; Qiu Y; Chen Y; Xu LW; Ding QR
    Yi Chuan; 2017 Mar; 39(3):177-188. PubMed ID: 28420614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enabling Precision Medicine with CRISPR-Cas Genome Editing Technology: A Translational Perspective.
    Ilahibaks NF; Hulsbos MJ; Lei Z; Vader P; Sluijter JPG
    Adv Exp Med Biol; 2023; 1396():315-339. PubMed ID: 36454475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells.
    Ma N; Zhang JZ; Itzhaki I; Zhang SL; Chen H; Haddad F; Kitani T; Wilson KD; Tian L; Shrestha R; Wu H; Lam CK; Sayed N; Wu JC
    Circulation; 2018 Dec; 138(23):2666-2681. PubMed ID: 29914921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods for Optimizing CRISPR-Cas9 Genome Editing Specificity.
    Tycko J; Myer VE; Hsu PD
    Mol Cell; 2016 Aug; 63(3):355-70. PubMed ID: 27494557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in CRISPR/Cas9 Directed Base Editing.
    Liu N; Zhou L; Qu J; Yao S
    Curr Gene Ther; 2021; 21(4):327-337. PubMed ID: 34225628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.